Get startedLog in
    Picture of Cellbion Co logo

    308430 — Cellbion Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Cellbion Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUSAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinal
    Net Income/Starting Line-4,778-6,382-3,633-7,266
    Depreciation
    Amortisation
    Non-Cash Items269-749-3,998-708
    Unusual Items
    Purchased R&D
    Other Non-Cash Items
    Changes in Working Capital34.71,7233,0782,572
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-3,491-4,640-3,936-4,777
    Capital Expenditures-248-525-433-167
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-6,7175,857-2,103-23,664
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-6,9645,331-2,536-23,831
    Financing Cash Flow Items32.617518284.3
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities10,206-2786,00228,949
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-249413-470340